A biosimilar to Remicade (infliximab) for treatment of adult and pediatric Crohn’s disease, adult ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.